Research Article

Immunological and Clinical Responses following the Use of Antiretroviral Therapy among Elderly HIV-Infected Individuals Attending Care and Treatment Clinic in Northwestern Tanzania: A Retrospective Cohort Study

Table 2

Clinical and immunological outcomes following the use of ART among HIV-infected adults attending care and treatment centre in Northwestern Tanzania, by age and sex.

VariableSex
Male (%)Female (%)
15–49≥50 15–49≥50

CD4 counts of cell/ul
 ≤35068 (34.3)15 (34.9)117 (25.6)12 (40.0)
 >35053 (26.8)12 (27.9)169 (37.0)10 (33.3)
 Missing77 (38.9)16 (37.2)171 (37.2)8 (26.7)
0.980.2
Change in ART
 Yes87 (43.9)29 (67.4)238 (52.1)16 (53.3)
 No109 (55.1)14 (52.6)216 (47.3)14 (46.7)
 Missing2 (1.0)0 (0.0)3 (0.7)0 (0.0)
0.020.9
Opportunistic infection at follow-up
 Yes15 (7.6)7 (16.3)23 (5.0)2 (6.7)
 No183 (92.4)36 (83.7)434 (95.0)28 (93.3)
 Missing0 (0.0)0 (0.0)0 (0.0)0 (0.0)
0.070.69
Reported admission at follow-up
 Yes27 (13.6)6 (14.0)72 (15.8)1 (3.3)
 No171 (86.4)37 (86.0)385 (84.2)29 (96.7)
 Missing0 (0.0)0 (0.0)0 (0.0)0 (0.0)
0.960.06
Other comedications at follow-up
 Yes179 (90.4)41 (95.4)421 (92.1)30 (100.0)
 No16 (8.1)2 (4.6)33 (7.2)0 (0.0)
 Missing3 (1.5)0 (0.0)3 (0.7)0 (0.0)
0.520.28